🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,589 results for “Pharma” Clear

  1. denileukin diftitox

    LIGAND PHARMACEUTICALS INC

    Drug/Agent Toxicity by Tissue/Organ

    phase 2 mab completed

    1 trial

  2. desogestrel/ethinyl estradiol and ethinyl estradiol

    Teva Pharma GmbH

    Hemostasis

    phase 2 small molecule completed

    1 trial

  3. edratide

    Teva Pharma GmbH

    Systemic Lupus Erythematosus

    phase 2 small molecule terminated

    1 trial

  4. eltrombopag

    Novartis Pharmaceuticals

    Thrombocytopaenia

    phase 2 small molecule completed

    1 trial

  5. entinostat

    Syndax Pharmaceuticals

    Estrogen Receptor-negative Breast Cancer

    phase 2 small molecule terminated

    1 trial

  6. entinostat

    Syndax Pharmaceuticals

    Epithelial Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  7. entinostat

    Syndax Pharmaceuticals

    Breast Cancer

    phase 2 small molecule completed

    4 trials

  8. erlotinib and bexarotene

    LIGAND PHARMACEUTICALS INC

    Carcinoma, Non-small-cell Lung

    phase 2 small molecule completed

    1 trial

  9. etiprednol dicloacetate

    Teva Pharma GmbH

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  10. fostamatinib

    RIGEL PHARMACEUTICALS INC

    Lymphoma

    phase 2 small molecule completed

    1 trial

  11. fremanezumab

    Teva Pharma GmbH

    Interstitial Cystitis

    phase 2 small molecule terminated

    1 trial

  12. glatiramer acetate

    Teva Pharma GmbH

    Crohns Disease

    phase 2 small molecule active

    1 trial

  13. glatiramer acetate 20 mg

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    phase 2 small molecule completed

    1 trial

  14. glatiramer acetate 20 mg

    Teva Pharma GmbH

    Relapse-Remitting Multiple Sclerosis

    phase 2 small molecule completed

    1 trial

  15. glatiramer acetate with minocycline

    Teva Pharma GmbH

    Relapse Remitting Multiple Sclerosis

    phase 2 small molecule completed

    1 trial

  16. glucagon

    Xeris Biopharma Holdings

    Post-bariatric Hypoglycemia

    phase 2 small molecule completed

    1 trial

  17. honeybee venom (Apitoxin (Korea) Apitox (USA))

    Apimeds Pharmaceuticals US

    Osteoarthritis of the Knee

    phase 2 small molecule completed

    1 trial

  18. ifezuntirgene inilparvovec, ifezuntirgene inilparvovec

    uniQure biopharma B.V.

    Huntington’s Disease

    phase 2 small molecule active

    1 trial

  19. iloperidone

    Vanda Pharmaceuticals Netherlands B.V.

    Hypertension

    phase 2 small molecule active

    1 trial

  20. infusion of MYOCET

    Teva Pharma GmbH

    Cerebral Lymphoma B Cell Refractory

    phase 2 small molecule terminated

    1 trial

  21. inhaled delta-8-THC 300mcg or 600mcg per dose

    Teva Pharma GmbH

    Cancer

    phase 2 small molecule terminated

    1 trial

  22. irbesartan

    LIGAND PHARMACEUTICALS INC

    Hypertension

    phase 2 small molecule completed

    1 trial

  23. laquinimod 0.3

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    phase 2 small molecule completed

    1 trial

  24. lestaurtinib

    Teva Pharma GmbH

    Polycythemia Vera

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources